Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG.

Am J Neurodegener Dis. 2014 Mar 28;3(1):19-32. eCollection 2014. Erratum in: Am J Neurodegener Dis. 2015;4(2):49.

2.

Erratum: Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue.

Love S, Chalmers K, Ince P, Esiri M, Attems J, Kalaria R, Jellinger K, Yamada M, McCarron M, Minett T, Matthews F, Greenberg S, Mann D, Kehoe PG.

Am J Neurodegener Dis. 2015 Dec 28;4(2):49. eCollection 2015.

3.
4.

APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature.

Nelson PT, Pious NM, Jicha GA, Wilcock DM, Fardo DW, Estus S, Rebeck GW.

J Neuropathol Exp Neurol. 2013 Jul;72(7):708-15. doi: 10.1097/NEN.0b013e31829a25b9.

5.

APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis.

Rannikmäe K, Kalaria RN, Greenberg SM, Chui HC, Schmitt FA, Samarasekera N, Al-Shahi Salman R, Sudlow CL.

J Neurol Neurosurg Psychiatry. 2014 Mar;85(3):300-5. doi: 10.1136/jnnp-2013-306485. Epub 2013 Oct 25.

6.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

7.
8.

Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.

Thal DR, Papassotiropoulos A, Saido TC, Griffin WS, Mrak RE, Kölsch H, Del Tredici K, Attems J, Ghebremedhin E.

Acta Neuropathol. 2010 Aug;120(2):169-83. doi: 10.1007/s00401-010-0707-9. Epub 2010 Jun 10.

PMID:
20535486
9.

Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy.

Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, Hyman BT, Rebeck GW.

Neurology. 1998 Apr;50(4):961-5.

PMID:
9566379
10.

Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.

Tanskanen M, Lindsberg PJ, Tienari PJ, Polvikoski T, Sulkava R, Verkkoniemi A, Rastas S, Paetau A, Kiuru-Enari S.

Neuropathol Appl Neurobiol. 2005 Dec;31(6):589-99.

PMID:
16281907
11.

Two types of sporadic cerebral amyloid angiopathy.

Thal DR, Ghebremedhin E, Rüb U, Yamaguchi H, Del Tredici K, Braak H.

J Neuropathol Exp Neurol. 2002 Mar;61(3):282-93.

PMID:
11895043
12.
13.

Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.

Liao F, Zhang TJ, Jiang H, Lefton KB, Robinson GO, Vassar R, Sullivan PM, Holtzman DM.

Acta Neuropathol Commun. 2015 Nov 10;3:70. doi: 10.1186/s40478-015-0250-y.

14.

ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.

Montañola A, de Retana SF, López-Rueda A, Merino-Zamorano C, Penalba A, Fernández-Álvarez P, Rodríguez-Luna D, Malagelada A, Pujadas F, Montaner J, Hernández-Guillamon M.

Neuromolecular Med. 2016 Mar;18(1):99-108. doi: 10.1007/s12017-015-8381-7. Epub 2015 Dec 14.

PMID:
26661731
15.

Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis.

Rannikmäe K, Samarasekera N, Martînez-Gonzâlez NA, Al-Shahi Salman R, Sudlow CL.

J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):901-8. doi: 10.1136/jnnp-2012-303898. Epub 2013 Mar 2. Review.

PMID:
23457231
16.

APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.

Nicoll JA, McCarron MO.

Amyloid. 2001 Jul;8 Suppl 1:51-5.

PMID:
11676291
17.

Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.

de Jager M, Drukarch B, Hofstee M, Brevé J, Jongenelen CA, Bol JG, Wilhelmus MM.

J Neurochem. 2015 Sep;134(6):1116-28. doi: 10.1111/jnc.13203. Epub 2015 Jul 7.

18.

Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.

Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM.

J Neurosci. 2005 Mar 16;25(11):2803-10.

19.

Cerebral amyloid angiopathy and its relationship to Alzheimer's disease.

Thal DR, Griffin WS, de Vos RA, Ghebremedhin E.

Acta Neuropathol. 2008 Jun;115(6):599-609. doi: 10.1007/s00401-008-0366-2. Epub 2008 Mar 28. Review.

PMID:
18369648
20.

Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.

Ringman JM, Sachs MC, Zhou Y, Monsell SE, Saver JL, Vinters HV.

JAMA Neurol. 2014 Jul 1;71(7):878-83. doi: 10.1001/jamaneurol.2014.681.

Supplemental Content

Support Center